Jump to section
To help people lead healthier, more active lives by empowering them with personalized, predictive, and preventive measures using the latest proven innovations in DNA and mobile technology.
93% employee growth in 12 months
On a mission to disrupt the healthcare industry, Prenetics is a leading genetic testing and digital health company. Its brands include Project Screen, DNAfit, and CircleDNA.
The company is well equipped to acheive its mission and decentralize a $1.3T industry given the world-class leadership team of tech and healthcare pioneers led by entrepreneur, Danny Yeung, founded of Venture Capital fund SXE Ventures.
Prenetics recently became publicly traded on the Nasdaq and brought in significant funding. Moving forward, the company is expected to continue its significant revenue growth trajectory with projected annual revenues of more than $600M in 2025.
Kirsty
Company Specialist at Welcome to the Jungle
Sep 2020
$15m
LATE VC
Oct 2017
$40m
SERIES B
Danny Yeung
(CEO)Previously Founding Partner at SXE Ventures for 7 years and Non-Executive Co-Founder at Fave for 6 years
Lawrence C.H. Tzang
(CSO)Previously Postdoctoral Research Fellow at City University of Hong Kong for 6 years